EpCAM regulates cell cycle progression via control of cyclin D1 expression.
Oncogene 32, 641-650 (2013)
The epithelial cell adhesion molecule (EpCAM) is an integral transmembrane protein that is frequently overexpressed in embryonic stem cells, tissue progenitors, carcinomas and cancer-initiating cells. In cancer cells, expression of EpCAM is associated with enhanced proliferation and upregulation of target genes including c-myc. However, the exact molecular mechanisms underlying the observed EpCAM-dependent cell proliferation remained unexplored. Here, we show that EpCAM directly affects cell cycle progression via its capacity to regulate the expression of cyclin D1 at the transcriptional level and depending on the direct interaction partner FHL2 (four-and-a-half LIM domains protein 2). As a result, downstream events such as phosphorylation of the retinoblastoma protein (Rb) and expression of cyclins E and A are similarly affected. In vivo, EpCAM expression strength and pattern are both positively correlated with the proliferation marker Ki67, high expression and nuclear localisation of cyclin D1, and Rb phosphorylation. Thus, EpCAM enhances cell cycle progression via the classical cyclin-regulated pathway.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Epcam ; Epicd ; Cyclin D1; Epithelial Ovarian-cancer ; Embryonic Stem-cells ; Ep-cam ; Hepatocellular-carcinoma ; Breast-cancer ; Potential Target ; Gene-expression ; Antigen Epcam ; Beta-catenin ; Fhl2
Keywords plus
Language
Publication Year
2013
Prepublished in Year
HGF-reported in Year
2013
ISSN (print) / ISBN
0950-9232
e-ISSN
0950-9232
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 32,
Issue: 5,
Pages: 641-650
Article Number: ,
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-501500-001
Grants
Copyright
Erfassungsdatum
2013-04-11